Insertable Cardiac Monitor
Cross-source consensus on Insertable Cardiac Monitor from 1 sources and 5 claims.
1 sources · 5 claims
Uses
How it works
Benefits
Risks & contraindications
Evidence quality
Highlighted claims
- Insertable cardiac monitors detected atrial fibrillation much more often than standard of care over three years in the STROKE AF trial. — Cost-effectiveness of an insertable cardiac monitor to detect atrial fibrillation in large- or small-vessel disease ischaemic stroke in the USA
- Insertable cardiac monitoring was evaluated as a strategy to detect atrial fibrillation after ischemic stroke attributed to large-artery atherosclerotic disease or small-vessel occlusive disease. — Cost-effectiveness of an insertable cardiac monitor to detect atrial fibrillation in large- or small-vessel disease ischaemic stroke in the USA
- The model assumed high device sensitivity and effectively perfect diagnostic specificity for atrial fibrillation detection. — Cost-effectiveness of an insertable cardiac monitor to detect atrial fibrillation in large- or small-vessel disease ischaemic stroke in the USA
- The model assumed an insertable cardiac monitor battery life of 4.5 years, after which detection rates returned to standard-of-care levels. — Cost-effectiveness of an insertable cardiac monitor to detect atrial fibrillation in large- or small-vessel disease ischaemic stroke in the USA
- Insertable cardiac monitoring carried modeled risks of explantation and infection. — Cost-effectiveness of an insertable cardiac monitor to detect atrial fibrillation in large- or small-vessel disease ischaemic stroke in the USA